This HTML5 document contains 94 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n12http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n13https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37166383
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в червні 2013 artículu científicu espublizáu en 2013 vedecký článok artigo científico article científic vetenskaplig artikel مقالة علمية نشرت في 28 يونيو 2013 wetenschappelijk artikel bilimsel makale vědecký článek wissenschaftlicher Artikel scientific article published on 28 June 2013 научни чланак articolo scientifico videnskabelig artikel article scientifique
p:P577
wds:Q37166383-76E8629F-4D13-4976-98ED-1F3772EA840A
wdt:P577
2013-06-28T00:00:00Z
p:P2888
wds:Q37166383-EFC9053E-75C8-495E-B0C9-7221C4B94090
wdt:P2888
n13:s10637-013-9976-1
p:P2860
wds:Q37166383-2809FC90-D63F-4E63-A06B-58A6D2410023 wds:Q37166383-0C4C34DC-31DA-431F-853F-513589321CBF wds:Q37166383-763BD46B-A5A2-4670-8F73-1C13BD760147 wds:Q37166383-2B3DE702-9F17-4F5A-98B1-53DE9639ACD5 wds:Q37166383-2B7F7C03-E639-4B21-A54F-9078D6A715D3 wds:Q37166383-3EF23571-B16F-487E-B6EB-F7CE77EB5C4E wds:Q37166383-8625A6A5-71F7-435A-9A36-D251A1EDE37C wds:Q37166383-A927BB66-EDAD-40C1-8715-78C28D90BA47 wds:Q37166383-7BA1F213-90AD-4D5F-8C48-876D3F2CE49D wds:Q37166383-81D296B1-1F8F-49F3-BC06-F89C78695F03 wds:Q37166383-FFAA15C0-E91C-479C-BA36-CEBA4A693D32
wdt:P2860
wd:Q36352235 wd:Q33386345 wd:Q43055420 wd:Q33380559 wd:Q71261788 wd:Q36848153 wd:Q25938997 wd:Q77556904 wd:Q72312443 wd:Q33387620 wd:Q29615946
p:P2093
wds:Q37166383-0D032975-FB35-4E26-AE1C-43C82FFE8520 wds:Q37166383-05641DF0-42F6-4442-9137-3C31578A7A63 wds:Q37166383-CECEC645-771A-42F1-A210-73B25FD083C4 wds:Q37166383-32075F4E-2912-4156-8172-7D9CC3FC8E33 wds:Q37166383-76BC7DC5-7618-4F0B-939E-DB58E314FA54
wdt:P2093
Cyndi Burkhardt Menggang Yu Robin Zon Cynthia Johnson Lida A Mina
rdfs:label
A phase II study of combined VEGF inhibitor A phase II study of combined VEGF inhibitor (bevacizumab+sorafenib) in patients with metastatic breast cancer: Hoosier Oncology Group Study BRE06-109 A phase II study of combined VEGF inhibitor (bevacizumab+sorafenib) in patients with metastatic breast cancer: Hoosier Oncology Group Study BRE06-109
skos:prefLabel
A phase II study of combined VEGF inhibitor A phase II study of combined VEGF inhibitor (bevacizumab+sorafenib) in patients with metastatic breast cancer: Hoosier Oncology Group Study BRE06-109 A phase II study of combined VEGF inhibitor (bevacizumab+sorafenib) in patients with metastatic breast cancer: Hoosier Oncology Group Study BRE06-109
schema:name
A phase II study of combined VEGF inhibitor (bevacizumab+sorafenib) in patients with metastatic breast cancer: Hoosier Oncology Group Study BRE06-109 A phase II study of combined VEGF inhibitor (bevacizumab+sorafenib) in patients with metastatic breast cancer: Hoosier Oncology Group Study BRE06-109 A phase II study of combined VEGF inhibitor
p:P50
wds:Q37166383-25D3BD98-CAF4-43BF-993C-A4792FF47866
wdt:P50
wd:Q91794468
p:P1476
wds:Q37166383-77D28CCD-37C3-4609-B6E4-F83749E0075C
wdt:P1476
A phase II study of combined VEGF inhibitor (bevacizumab+sorafenib) in patients with metastatic breast cancer: Hoosier Oncology Group Study BRE06-109
p:P304
wds:Q37166383-2A3815B9-B745-467E-9144-F219DDF564D3
wdt:P304
1307-1310
p:P31
wds:Q37166383-AB74D680-A59D-4FFE-85DC-2D2FBAE79EB0
wdt:P31
wd:Q13442814
p:P921
wds:Q37166383-8E5B3EFE-298F-44FD-868B-799F1AFEA782 wds:Q37166383-554D69FD-EA30-4283-8E94-FAB0B4160F9F
wdt:P921
wd:Q413299 wd:Q12859063
p:P698
wds:Q37166383-AC733BB3-B772-4D1D-AD32-98BF4789C2AD
wdtn:P698
n8:23812905
wdt:P698
23812905
p:P1433
wds:Q37166383-EFD79A15-CB97-4866-B627-B023FF570829
wdt:P1433
wd:Q2312231
p:P433
wds:Q37166383-7E4B4F05-B84F-4C1E-BF80-9F0821221F29
p:P478
wds:Q37166383-9B2B1FE7-88FB-44FF-A3F7-F5004B4E000B
wdt:P433
5
wdt:P478
31
p:P356
wds:Q37166383-1A853C25-83B9-491E-A765-960E56BF6D6D
wdtn:P356
n12:S10637-013-9976-1
wdt:P356
10.1007/S10637-013-9976-1
p:P275
wds:Q37166383-c06010fa-ef1e-48af-b6ef-0a311c398f42
p:P6216
wds:Q37166383-f83f5a55-ef5b-467e-b185-d2d674dd3007
wdt:P275
wd:Q44128984
wdt:P6216
wd:Q50423863
p:P5875
wds:Q37166383-239C9A1E-B4F6-4D0A-8A27-653005370421
wdt:P5875
243969135
p:P932
wds:Q37166383-E7D0230E-E1CF-4B92-B085-29C038EF1781
wdt:P932
3771371